bioprotech (199290) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for bioprotech is dated 2023-12-11; the most recent is 2026-05-31. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | SELL | 임원퇴임 | 이병탁 Lee Byung-tak | committee member | -25.0K | ₩410 | -6.1% | ₩10M ($7K) |
| 2024-10-07 | SELL | 증여 | 이성제 Lee Seong-je | Managing Director | -100.1K | ₩500 | +28.0% | ₩50M ($35K) |
| 2024-03-15 | BUY | 기타 | 김병전 Kim Byeong-jeon | CEO | 16.3K | ₩1,099 | -67.2% | ₩18M ($12K) |
| 2024-03-15 | BUY | 기타 | 임재상 Jaesang Lim | moving | 39.1K | ₩1,099 | -67.2% | ₩43M ($30K) |
| 2024-03-15 | BUY | 기타 | 석희복 Seok Hee-bok | Managing Director | 19.5K | ₩1,099 | -67.2% | ₩21M ($15K) |
| 2024-03-15 | BUY | 기타 | 박익로 Park Ik-ro | CEO | 1.9K | ₩1,099 | -67.2% | ₩2M ($1K) |
| 2024-03-15 | BUY | 기타 | 이성제 Lee Seong-je | Managing Director | 39.1K | ₩1,099 | -67.2% | ₩43M ($30K) |
| 2024-03-15 | SELL | 기타 | 케이씨-쥐피(KC-GP) 신기술조합 제일호 KC-GP New Technology Association Jeilho | - | -5.1M | ₩1,099 | +67.2% | ₩5.6B ($3.9M) |
| 2023-12-11 | BUY | 수증 | 석희복 Seok Hee-bok | Managing Director | 1.1K | ₩1,238 | -70.9% | ₩1M ($924) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for bioprotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.